NIND

AcronymDefinition
NINDNational Industries Group Holding (stock symbol)
NINDNon-Inflammatory Neurological Disease
References in periodicals archive ?
The best man was Mr D Napierala, the usher was Mr R Day, the bride's brother, and the groomsman was Mr R Nind, the bride's stepbrother.
Dr Nind said the deceased had a long medical history of alcohol abuse but said the post mortem examination revealed no drugs or injuries that were likely to have caused her death.
All four have been leading lights in the Sharks' second string this season, with Bahadori, Bessell and Nind having all had brief tastes of life in the first team after receiving late call-ups.
Meanwhile, (MARAKEZ), (CABLETV), (NIND), (ABAR), and (SGC) stocks were the top gainers.(end) fh.afh.ba KUNA 240955 Jun 13NNNN
Maintaining normal blood pressure "significantly reduced white matter lesion accumulation in people who had a higher chance of experiencing this kind of damage because they had high blood pressure," Clinton Wright, lead researcher and director of the Division of Clinical Research at NINDS, said in a statement.A
Clinton Wright, director de la Division de Investigacion Clinica del NINDS.
After decades of uncertainty about how to manage blood sugar in acute stroke patients we finally have strong clinical evidence that aggressive lowering does not improve patient outcome, said Walter Koroshetz, M.D., NINDS director.
MONROVIA, Calif., June 18, 2018 -- AcuraStem was awarded a $3.7 million Small Business Innovation Research (SBIR) Fast-Track grant by the National Institute of Neurological Disorders and Stroke (NINDS) to continue development of a small molecule therapeutic, AS2015, to treat patients with the genetic form of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) caused by expansion repeats in the gene C9ORF72.
Global Banking News-June 21, 2018-Aquinnah Pharmaceuticals wins USD3.4m NINDS grant to advance new therapies in treating ALS
M2 EQUITYBITES-June 21, 2018-Aquinnah Pharmaceuticals wins USD3.4m NINDS grant to advance new therapies in treating ALS
M2 PHARMA-June 21, 2018-Aquinnah Pharmaceuticals wins USD3.4m NINDS grant to advance new therapies in treating ALS
Under this new award, the National Institute of Neurological Disorders and Stroke (NINDS), which manages the BPN, now also has the opportunity to leverage AMRI's additional capacity and medicinal chemistry capabilities at its state-of-the-art Drug Discovery Center of Excellence in Buffalo, New York.